Impax Labs (IPXL) Promotes VP Bryan Reasons to CFO

Impax Laboratories, Inc. (Nasdaq: IPXL) announced today that Bryan M. Reasons has been appointed senior vice president and chief financial officer (CFO). Mr. Reasons, 45, joined Impax Laboratories in January 2012 as vice president, Finance, and has served as acting CFO since June 2012.

Prior to joining Impax Laboratories, Mr. Reasons served as vice president, Finance, and as vice president, Risk Management and General Auditor, at Cephalon, Inc. (Cephalon), a biopharmaceutical company. Following the acquisition of Cephalon by Teva Pharmaceutical Industries Ltd. (Teva), he served briefly as the vice president, Finance, of Teva. Prior to joining Cephalon in 2005, Mr. Reasons held various finance management positions at Dupont and began his career at PricewaterhouseCoopers LLP, where he held positions of increasing responsibility. He earned a bachelor’s degree in accounting from the Pennsylvania State University and an M.B.A. from Widener University and is a certified public accountant.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Coty's chief people officer to resign in August
• REalloys CFO resigns; Craig Cunningham appointed as replacement
• Nvidia taps Microsoft veteran as new field operations chief